1 month Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Receives Consensus Rating of “Moderate Buy” from AnalystsMarketBeat
Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the eight analysts that are covering the company, Marketbeat.com reports. Four analysts have rated the stock wit…
X